View in EDS PDF Full Text

Baseline immune signature score of Tregs × HLA-DR+CD4+ T cells × PD1+CD8+ T cells predicts outcome to immunotherapy in cancer patients.

Saved in:
Bibliographic Details
Title: Baseline immune signature score of Tregs × HLA-DR+CD4+ T cells × PD1+CD8+ T cells predicts outcome to immunotherapy in cancer patients.
Authors: Mispelbaum R; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany., Hattenhauer ST; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany., Held SAE; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany., Brossart P; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany., Heine A; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.
Source: Frontiers in immunology [Front Immunol] 2022 Nov 28; Vol. 13, pp. 1054161. Date of Electronic Publication: 2022 Nov 28 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36518753
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Baseline immune signature score of Tregs × HLA-DR<superscript>+</superscript>CD4<superscript>+</superscript> T cells × PD1<superscript>+</superscript>CD8<superscript>+</superscript> T cells predicts outcome to immunotherapy in cancer patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mispelbaum+R%22">Mispelbaum R</searchLink>; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Hattenhauer+ST%22">Hattenhauer ST</searchLink>; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Held+SAE%22">Held SAE</searchLink>; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Brossart+P%22">Brossart P</searchLink>; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Heine+A%22">Heine A</searchLink>; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2022 Nov 28; Vol. 13, pp. 1054161. <i>Date of Electronic Publication: </i>2022 Nov 28 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36518753
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2022.1054161
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1054161
    Titles:
      – TitleFull: Baseline immune signature score of Tregs × HLA-DR+CD4+ T cells × PD1+CD8+ T cells predicts outcome to immunotherapy in cancer patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mispelbaum R
      – PersonEntity:
          Name:
            NameFull: Hattenhauer ST
      – PersonEntity:
          Name:
            NameFull: Held SAE
      – PersonEntity:
          Name:
            NameFull: Brossart P
      – PersonEntity:
          Name:
            NameFull: Heine A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 11
              Text: 2022 Nov 28
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1